- Home
- VNDA vs NNOX Comparison
VNDA vs NNOX Comparison
Compare VNDA & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- NNOX
- Stock Information
- Founded
- VNDA 2002
- NNOX 2011
- Country
- VNDA United States
- NNOX Israel
- Employees
- VNDA N/A
- NNOX N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- NNOX Medical Electronics
- Sector
- VNDA Health Care
- NNOX Health Care
- Exchange
- VNDA Nasdaq
- NNOX Nasdaq
- Market Cap
- VNDA 249.4M
- NNOX 248.7M
- IPO Year
- VNDA 2006
- NNOX 2020
- Fundamental
- Price
- VNDA $4.39
- NNOX $3.91
- Analyst Decision
- VNDA Strong Buy
- NNOX Strong Buy
- Analyst Count
- VNDA 2
- NNOX 2
- Target Price
- VNDA $16.50
- NNOX $8.50
- AVG Volume (30 Days)
- VNDA 346.2K
- NNOX 1.1M
- Earning Date
- VNDA 11-05-2025
- NNOX 08-12-2025
- Dividend Yield
- VNDA N/A
- NNOX N/A
- EPS Growth
- VNDA N/A
- NNOX N/A
- EPS
- VNDA N/A
- NNOX N/A
- Revenue
- VNDA $203,467,000.00
- NNOX $11,886,000.00
- Revenue This Year
- VNDA $15.45
- NNOX $24.12
- Revenue Next Year
- VNDA $37.82
- NNOX $160.56
- P/E Ratio
- VNDA N/A
- NNOX N/A
- Revenue Growth
- VNDA 11.78
- NNOX 17.36
- 52 Week Low
- VNDA $3.81
- NNOX $3.63
- 52 Week High
- VNDA $5.55
- NNOX $11.00
- Technical
- Relative Strength Index (RSI)
- VNDA 42.54
- NNOX 42.57
- Support Level
- VNDA $4.36
- NNOX $3.82
- Resistance Level
- VNDA $4.64
- NNOX $4.03
- Average True Range (ATR)
- VNDA 0.16
- NNOX 0.16
- MACD
- VNDA -0.03
- NNOX 0.05
- Stochastic Oscillator
- VNDA 5.36
- NNOX 65.12
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.